Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Small for Gestational Age Infants or Appropriate for Gestational Age Infants
and you are
between 18 and 60
years old
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

Numerous studies have recommended the use of n-3 PUFA supplementation during human pregnancy and lactation for the prevention of preterm birth, beneficial effects on fetal development, visual and cognitive development and other functional outcomes of the infants. The aim of the present study is to assess the correlation between ratio of n-3:n-6 fatty acid and inflammation markers in SGA infants compared with appropriate for gestational age (AGA) infants. The investigators hypothesize that in SGA infants n-3 and n-6 fatty acid concentrations in cord blood will differ from those observed in AGA and might correlate with the level of circulating mediators.

Provided treatments

  • Procedure: Blood test
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02887664. The sponsor of the trial is Tel-Aviv Sourasky Medical Center and it is looking for 60 volunteers for the current phase.
Official trial title:
The Correlation Between the n-6:n-3 Ratio and Inflammatory Markers in Small for Gestational Age (SGA) Infants Compared With Appropriate for Gestational Age (AGA) Infants